La Lettre d`addictovigilance – n°14, mars 2017

La Lettre d’addictovigilance – n°14, mars 2017!
!
!
"!#$%&'()(*'!+(!,%!+-.,(.$!/!%''(*'&-*!0!*(!1%2!3%*%,&2($!,%!1$(24$&1'&-*!+5-674-+-*(!8!
"#$%&'! (%#)(%#'! *++,#'-! )#'! ./++,#'! .#! 0#+1#! #1! .2%1&)&'*1&/+! /+1! 3/+14,! %+#! 145'! +#11#!
*%63#+1*1&/+!.#!)*!7/+'/33*1&/+!.#'!.&88,4#+1#'!8/43#'!.9/:;7/./+#!.*+'!)*!$/$%)*1&/+!6,+,4*)#!
84*+<*&'#=!>+!$*4*))5)#-!/+!/?'#40#!%+#!*%63#+1*1&/+!.#!)9%'*6#!$4/?),3*1&(%#!.#!7#!3,.&7*3#+1!
@*..&71&/+-! %'*6#! 4,74,*1&8-! '%?'1&1%1&/+! /$&*7,#-! $4&'#! $*4! 0/&#! &+A*),#! #1B/%! &+C#71*?)#D! *&+'&!
(%9%+#!*%63#+1*1&/+!.#'!#88#1'!&+.,'&4*?)#'-!'/%0#+1!.*+'!)#!7*.4#!.9%+#!&+.&7*1&/+!A/4'!EFF=!
G*$$#)/+'! (%#! )9/:;7/./+#! #'1! .#%:! 8/&'! $)%'!$%&''*+1#! (%#! )*! 3/4$A&+#-! (%#! )#! 4&'(%#!
.9*..&71&/+!+9#'1!$*'!+%)-!+/1*33#+1!.*+'!%+!7/+1#:1#!.#!0%)+,4*?&)&1,!#1!(%9#))#!#'1!&+.&(%,#!.*+'!
)#'!./%)#%4'!+#!$/%0*+1!H14#!7/44#71#3#+1!14*&1,#'!(%#!$*4!.#'!*+1*)6&(%#'!/$&*7,'!8/41'=!
I*!$4%.#+7#!#'1!.#!3&'#!7A#J!)#'!$#4'/++#'!*;*+1!.#'!*+1,7,.#+1'!.9*..&71&/+-!3*&'!,6*)#3#+1!
7A#J!)#! '%C#1! K6,!(%&! *! %+#! '#+'&?&)&1,! $*41&7%)&54#! *%:! #88#1'! &+.,'&4*?)#'! 7#+14*%:! @7/+8%'&/+D-!
4#'$&4*1/&4#'! #1! .&6#'1&8'! .#'! /$&*7,'-! *&+'&! (%9%+#! 8/+71&/+! 4,+*)#! '/%0#+1! *)1,4,#=! LA#J! 7#'!
.#4+&#4'-! )9/:;7/./+#! ./&1! H14#! &+'1*%4,#! M! )*! $/'/)/6&#! )*! $)%'! 8*&?)#-! #+! *%63#+1*+1! 145'!
$4/64#''&0#3#+1!)*!$/'/)/6&#=!!
L#11#!$4%.#+7#!#'1!M!*./$1#4!?&#+!'N4!$/%4!1/%'!)#'!/$&*7,'!@0/&4!I*!I#114#!.2*..&71/0&6&)*+7#!+OPD!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !E3,)&#!"*0#)%;!
"!9:'-.$*()(*'!+(!'$-1&4%)&+(!
"#$%&'!QRST-!)#!4,'#*%!.#'!7#+14#'!.9*..&71/0&6&)*+7#-!*!,1,!*)#41,!.*+'!)#!7*.4#!.#!)9#+(%H1#!'%4!
)#'! /4./++*+7#'! 8*)'&8&,#'! UVWEX! @U4./++*+7#'! V%'$#71#'! W+.&7*1#%4! .9E?%'! X/''&?)#D! '%4! %+!
.,1/%4+#3#+1! $4/?*?)#! .#! 7/));4#! 7/+1#+*+1! .%! 14/$&7*3&.#! @F;.4&*1&7%3YD! @SD=! X)%'&#%4'!
$A*43*7&#'! '#! '/+1! 3*+&8#'1,#'! *$45'! (%#! .#'! A/33#'! *%! 7/3$/41#3#+1! '%'$#71! '/&#+1! 0#+%'!
.#3*+.#4! 7#! 3,.&7*3#+1-! *0#7-! 3*&'! $*48/&'! '*+'-! /4./++*+7#=! L#! '&6+*)#3#+1-! *%! .,$*41!
1/%)/%'*&+-!'#3?)#!'#! .&88%'#4! *%! +&0#*%! +*1&/+*)!#1!#+! E(%&1*&+#-! &)! '#3?)#!;!*0/&4!%+#! .#3*+.#!
$)%'!'/%1#+%#!7#'!.#4+&#4'!3/&'=!!
!!!!!I#!14/$&7*3&.#!#'1!%+!7/));4#!3;.4&*1&(%#-!04*&'#3?)*?)#3#+1!.,1/%4+,!.#!'/+!%1&)&'*1&/+!$/%4!
'#'! $4/$4&,1,'! *14/$&+&(%#'=! I#! .,1/%4+#3#+1! .#! 7#! 3,.&7*3#+1! $*4! 0/&#! &+14*0#&+#%'#-! M! 0&',#!
4,74,*1&0#-!*!'%41/%1!,1,!4*$$/41,!.*+'!)#'!$*;'!.9>%4/$#!.#!)9>'1-!+/1*33#+1!#+!G%''&#!/Z!%+!.,75'!
*%4*&1!,1,! *114&?%,! M!7#11#! 7/+'/33*1&/+! 3*&'!*%''&! #+! W1*)&#!@Q-PD=! I#'! 0#+1#'! .#! 14/$&7*3&.#! #+!
G%''&#!/+1!.9*&))#%4'! ,1,! 3%)1&$)&,#'! $*4!SP!*%! 7/%4'! .#'! [!.#4+&54#'!*++,#'-! .%! 8*&1! .#!7#1!%'*6#!
.,1/%4+,=! I9%1&)&'*1&/+! .%! 14/$&7*3&.#! #+! W\! '#4*&1! '%41/%1! /?'#40,#! 7A#J! .#'! 7/+'/33*1#%4'!
.9/$&*7,'!(%&!4#7A#47A#4*&#+1!%+#!*%63#+1*1&/+!.#'!#88#1'!$/'&1&8'!.#!)9A,4/]+#!@#%$A/4&#-!7*)3#D-!
%+#!*11,+%*1&/+!.#'!';3$1^3#'!.#!'#04*6#!*%:!/$&*7,'-!%+#!$)%'!64*+.#!.&'$/+&?&)&1,-!%+!$4&:!$)%'!
8*&?)#-! .#'! #88#1'! $)%'! 4*$&.#'! @T_`D=! I*! .#'74&$1&/+! '%4! .#'! 8/4%3'! '%4! W+1#4+#1! *! 7#41*&+#3#+1!
7/+14&?%,!M!)*!.&88%'&/+!.#!7#11#!$4*1&(%#=!U+!+#!4#14/%0#!.*+'!)*!)&11,4*1%4#!'7&#+1&8&(%#!(%9%+!7*'!
.*1*+1! .#! Sab[! .9*..&71&/+! *%! 14/$&7*3&.#! #+! *''/7&*1&/+! *0#7! %+! *%14#! 7/));4#! 3;.4&*1&(%#-! )#!
7;7)/$#+1/)*1#!@bD=!!!!!!!!!!!!!!!!!!!!!!!E"!
1#BIP31.fr,!2015,!22.!2#Bersani!FS,!Hum!Psychopharmacol!Clin!Exp!2015.!3#Bozkurt!M,!Subst!Abuse!2014.!4#Spagnolo!PA,!
Clin! Neuropharmacol! 2013.! 5#Bersani! FS,! Gen! Hosp! Psychiatry! 2013.! 6#Prilutskaya! MV,! ESJ! 2015.! 7#Ostler! HB,! Arch!
Ophtalmol!1975.!! !!!!!!!!!!!!!!!!!!!!!!!!
!
"!;:<,()(*'%'&-*!+(2!2'.1:=&%*'2!/!(*'$:(!(*!>&<.(.$!+(!*-.>(,,(2!)(2.$(2!(*!%>$&,!?@AB!
!"!!C-,1&+()!/!%11,&4%'&-*!1%$'&(,,(!+(!,%!$:<,()(*'%'&-*!+(2!2'.1:=&%*'2!!
I#! J/)$&.#3-! &+.&(%,! .*+'! )9&+'/3+&#! /77*'&/++#))#-! $#+.*+1! Q! M! [! C/%4'-! #1! )9&+'/3+&#!
14*+'&1/&4#-!$#+.*+1!Q!M!P!'#3*&+#'-!4#C/&+.4*!)#!SR!*04&)!QRSb-!)#'!3,.&7*3#+1'!&+'74&1'!'%4!I&'1#!W!
./+1! )*! $4#'74&$1&/+! #'1! '/%3&'#! M! )9*$$)&7*1&/+! $*41&#))#! .#! )*! 4,6)#3#+1*1&/+! .#'! '1%$,8&*+1'!c!
/4./++*+7#!',7%4&',#-! $/'/)/6&#! 3#+1&/++,#! #+! 1/%1#'! )#114#'-! 7A#0*%7A#3#+1! .#! $4#'74&$1&/+!
&+1#4.&1=! d/%1#8/&'-! &)! +9;! *%4*! $*'!.#! .,)*&! .#! 7*4#+7#! .#! P! C/%4'!+&! .9/?)&6*1&/+! .9*47A&0*6#! .#'!
/4./++*+7#'!$*4!)#!$A*43*7&#+!@SD=!!
L/33#! $/%4! 1/%'! )#'! A;$+/1&(%#'-! )#! 1*%:! .#! 4#3?/%4'#3#+1! $*4! )9*''%4*+7#! 3*)*.&#! *! ,1,!

Pour%tout%renseignement%sur%les%substances%psychoactives%(hors%tabac%et%alcool)%et%notification%de%cas%d'abus,%pharmacodépendance,%usage%détourné%:%
D(*'$(!+5%++&4'->&<&,%*4(!!
Département%de%pharmacologie%>%Hôpital%Pellegrin,%CHU,%33076%Bordeaux%cedex%
Tel%:%05%56%98%16%09%>%05%56%7(9%55%08)%>%mail%:%ceip>addictovigilance@u>bordeaux.fr%
Directrice%de%la%publication>rédactrice%en%chef%:%Amélie%Daveluy%;%ISSN%%2495>1854.%!I*!)#114#!!.9*..&71/0&6&)*+7#!#'1!.&'$/+&?)#!'%4!eee=$A*43*7/#$&=#%B!
!
.&3&+%,!M!S[!f!#+!.,7#3?4#!QRST-!#+!4*&'/+!.9%+!'#40&7#!3,.&7*)!4#+.%!8*&?)#!@QD=!I*!3H3#!*++,#-!
)*!4,,0*)%*1&/+!4,*)&',#!$*4!)9*6#+7#!#%4/$,#++#-!#+!4*&'/+!.#!14/%?)#'!.#!)*!0&6&)*+7#!4,'&.%#)'!)#!
)#+.#3*&+!.#!)*!$4&'#-!*!7/+.%&1!)9EgVF!M!4*$$#)#4!.#'!$4&+7&$#'!.#!?*'#!c!&3$/41*+7#!.9%+#!.%4,#!
.9%1&)&'*1&/+!)*!$)%'!?450#!$/''&?)#-!M!)*!$)%'!8*&?)#!$/'/)/6&#!#88&7*7#-!*%!3/3#+1!.%!7/%7A#4!#1!*%!
3/&+'!h!A#%4#'!*0*+1!)#!4,0#&)!$4,0%-!'9*?'1#+&4!.#!4#$4#+.4#!.%!J/)$&.#3!#+!7*'!.#!4,0#&)!#+!3&)&#%!
.#! +%&1! @PD=! L#11#! 4,,0*)%*1&/+! #%4/$,#++#! *! ,1,! 8*&1#! *$45'! )*! .,7&'&/+! .#! )*! Food! and! Drug!
Administration! @i"ED! *%:! >1*1'_j+&'! .#! 4#0/&4! )*! $/'/)/6&#! k! 3*&'-! 7/+14*&4#3#+1! M! 7#! (%&! *! ,1,!
.,7&.,! $*4! )*! i"E! @+/1*33#+1! $/'/)/6&#! 3*:&3*)#! M! [! 36! 7A#J! )#'! 8#33#'-! #+! 4*&'/+! .#! )*!
'%40#+%#!.9*77&.#+1'!.#!)*!7&47%)*1&/+!)#!)#+.#3*&+!.#!)*!$4&'#!#1!.#!./++,#'!$A*43*7/7&+,1&(%#'!
3/+14*+1!.#'!7/+7#+14*1&/+'!$)*'3*1&(%#'!$)%'!,)#0,#'!7A#J!)#'!8#33#'!(%#!7A#J!)#'!A/33#'D!@TD-!
)9*6#+7#!#%4/$,#++#!+9*!$*'!3/.&8&,!)*!$/'/)/6&#!7A#J!)#'!8#33#'!l!G*$$#)/+'!(%2#+!QRS[-!!)*!m*%1#!
E%1/4&1,!.#!V*+1,!*!$%?)&,!.#!+/%0#))#'!4#7/33*+.*1&/+'!'%4!)#'!?#+J/.&*J,$&+#'!#+!6,+,4*)!#1!)#'!
A;$+/1&(%#'! #+! $*41&7%)&#4! c! Arrêt! des! benzodiazépines! et! médicaments! apparentés!:! démarche! du!
médecin!traitant!en!ambulatoire!k!Quelle!place!pour!les!benzodiazépines!dans!l’insomnie!n!@[D=!!!!
E)/4'!(%#!)#!J/)$&.#3!,1*&1!.,CM-!.#$%&'!.#'!*++,#'-!leader!.#'!3,.&7*3#+1'!3#+1&/++,'!.*+'!
)9#+(%H1#!UVWEX! @cf.! supraD-! )#!+/3?4#!#1! )*! 64*0&1,! .#'! 7*'! .9*..&71&/+!/%! .9%'*6#! $4/?),3*1&(%#!
/+1! *%63#+1,! @$/'/)/6&#! 14/$! ,)#0,#-! .%4,#! .9%1&)&'*1&/+! 14/$! )/+6%#-! '/%3&''&/+! 7A&3&(%#-!
.,1/%4+#3#+1!.#!)*!0/&#!.9%1&)&'*1&/+-!4#7A#47A#!.9#88#1!$';7A/_*71&8!4#+8/4<*+1D=!!
I#'! +/%0#))#'! 456)#'! .#! $4#'74&$1&/+! .%! J/)$&.#3! 4&'(%#+1! .#! '%4$4#+.4#!)#'! $*1&#+1'=!
d/%1#8/&'-!)*!8/47#!';3?/)&(%#!.#!'/+!*''&3&)*1&/+!M!%+!'1%$,8&*+1!$*41&7&$#4*!7#41*&+#3#+1!M!)#%4!
'#+'&?&)&'*1&/+!*%:!456)#'!.#! ?/+! %'*6#=!"#'!4#$/41'!0#4'!.9*%14#'!?#+J/.&*J,$&+#'-!#+!$*41&7%)&#4!
0#4'!)*!J/$&7)/+#-!'/+1!$4,0&'&?)#'=!!
X/%4! 3,3/&4#-! 4*$$#)/+'! (%#! )*!$4#'74&$1&/+! '%4! /4./++*+7#! ',7%4&',#! .#! 1/%1#'! )#'!
?#+J/.&*J,$&+#'!@./+1! )#!J/)$&.#3D-! *0*&1!,1,!#+0&'*6,#! .5'!QRSP! $*4! )9EgVF! @`-! bD! #1! (%#! )#'!
3/.*)&1,'!.9%1&)&'*1&/+!.#'!?#+J/.&*J,$&+#'!'/+1!!)/&+!.9H14#!/$1&3*)#'!@hD=!!
!!!!!!!!!F*4&#!o*%3#0&#&))#!
1#ANSM,!Communiqué,!11/01/2017.!2#Avis!relatif!à! la!décision!de!l’UNCAM,!JO,!14/11/2014.! 3#EMA,!Pharmacovigilance!
Risk! Assessment! Committee,! 24/04/2014.! 4#fda.gov.! 5#has#sante.fr.! 6,7#ANSM,! Commissions! stupéfiants! et! psychotropes,!
20/06/2013!et!21/11/2013.!8#Benard#Laribière!#1!*),!Pharmacoepidemiol!Drug!Saf!2016.!
!
! "!E:'%)&*(!&*F(4'%3,(!/!4,%22()(*'!2.$!,%!,&2'(!+(2!2'.1:=&%*'2!
I*! p,1*3&+#! &+C#71*?)#-! *+#'1A,'&(%#! %1&)&',! #+! 3,.#7&+#! A%3*&+#! @4,'#40,#! M! )9%'*6#!
A/'$&1*)&#4!/%!#+!'&1%*1&/+!.9%46#+7#D!#1!0,1,4&+*&4#!@.,)&04*+7#!&+1#4.&1#!*%!$%?)&7D!0*!H14#!7)*'',#!
'%4!)*!)&'1#!.#'!'1%$,8&*+1'!M!$*41&4!.%!QT!*04&)!QRSb!@SD=!I#!7/+14^)#!.#'!7/+.&1&/+'!.9%1&)&'*1&/+!.#!
7#! 3,.&7*3#+1! (%&! ,1*&1! '/%3&'! M! %+#! *$$)&7*1&/+! $*41&#))#! .#! )*! 4,6)#3#+1*1&/+! .#'! '1%$,8&*+1'!
@'1/7p*6#! ',7%4&',-! .,7)*4*1&/+! .#'! 0/)'D! @0/&4! I*! I#114#! .9*..&71/0&6&)*+7#! +OSPD!0*! H14#! *&+'&!
4#+8/47,!c!'*!$4#'74&$1&/+!'#4*!'/%3&'#!M!)*!4,6)#3#+1*1&/+!.#'!'1%$,8&*+1'!@/4./++*+7#!',7%4&',#-!
456)#! .#! 7A#0*%7A#3#+1-! .,)*&! .#! 7*4#+7#-! etc=D-! .#! 3H3#! (%#! '/+! 7&47%&1! @'1/7p*6#! ',7%4&',-!
14*<*?&)&1,-!7/3$1*?&)&1,!.#'!?*)*+7#'!#+14,#'_'/41&#'!'%4!%+!4#6&'14#!'$,7&8&(%#-!etc.D=!
L#!7)*''#3#+1!#+!i4*+7#-!'%4!$4/$/'&1&/+! .#! )9EgVF! #1! .#! )9EgV>V! @7#11#! .#4+&54#! '9/77%$*+1!
.#'!3,.&7*3#+1'!0,1,4&+*&4#'D!#'1!C%'1&8&,!$*4!)*!'%40#+%#!.#!$)%'!#+!$)%'!84,(%#+1#!.#!7*'!.9*?%'-!
*0#7!1*?)#*%!7)&+&(%#!$*48/&'!64*0#-!)#!$)%'!'/%0#+1!)/4'!.#!7/+'/33*1&/+!#+!3&)&#%!8#'1&8-!*&+'&!(%#!
$*4! )*! A*%''#! .%! 14*8&7!@QD=! I#! L/3&1,! .9#:$#41'! '%4! )*! $A*43*7/.,$#+.*+7#! .#! )9U46*+&'*1&/+!
F/+.&*)#!.#!)*!V*+1,!@UFVD-!via!)*!L/33&''&/+!.#'!'1%$,8&*+1'!.#!)9Ugj-!*!'/%3&'!7#!3,.&7*3#+1!M!
%+#!'%40#&))*+7#!&+1#4+*1&/+*)#!.#$%&'!.#!+/3?4#%'#'!*++,#'!@PD=!d/%1#8/&'-!#+!4*&'/+!.%!?,+,8&7#!
(%&!)9#3$/41#!'%4!)#'!4&'(%#'! .9%'*6#!.,1/%4+,-!.9*?%'!#1! .#!14*8&7-!&)!#'1!/$$/',!M! '/+!7)*''#3#+1!
&+1#4+*1&/+*)!.#3*+.,!$*4!7#41*&+'!$*;'!/Z!)*!p,1*3&+#!$/'#!%+!4,#)!$4/?)53#=!!>+!#88#1-!7#!7/3&1,!
7/+'&.54#! (%9%+! 7)*''#3#+1! &+1#4+*1&/+*)! $/%44*&1! 7/3$4/3#114#! )9*775'! M! 7#! 3,.&7*3#+1-! 7)*'',!
3,.&7*3#+1! #''#+1&#)! $*4! )9UFV! #+! Sah[-! .*+'! .#'! $*;'! M! 8*&?)#'! 4#''/%47#'-! /Z! &)! #'1! '/%0#+1! )#!
'#%)!3,.&7*3#+1!*+#'1A,'&(%#!.&'$/+&?)#=!!!!!!!!!!!!!!!!!!!!Fo!
S_ANSM,!Communiqué!26/01/2017.!2#ANSM,!Commissions!stupéfiants!et!psychotropes,!19/06/2014.!3#WHO!recommends!
against!International!control!of!ketamine,!www.who.int!